{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/18647"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/18647","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Study of drug delivery and cell encapsulation using biocompatible hydrogel","abstract":"Hydrogel particles encapsulating biomolecules or living cells are becoming an attractive means to mediate drug delivery or facilitate cell-based treatment of diseases. These particles are capable of maintaining drug stability/cell viability and providing specific drug release profiles. The selection of specific hydrogel and particle size depends on the administration routes, properties of the therapeutics and desired release profiles, and dictates the fabrication methods. We have chosen to design and fabricate hydrogel particles as a means to improve the efficacy of drug delivery utilizing mechanical, hydrodynamic and electric forces (precision particle fabrication (PPF) method and its modified scheme). Using such precision particles, we studied the drug release mechanisms that may help improve the design of new drug delivery vehicles. Monodisperse gelatin microspheres, fabricated via the electric field assisted PPF method, allowed detailed analysis of drug release without uncertainties ascribable to nonuniform particles. The results from this analysis, including zeta potential, particle swelling ratio, and intraparticle drug distributions, led to a release model, based on the reaction-diffusion and Michaelis-Menten kinetics. This model elucidates the effect of glutaraldehyde, a cross-linking agent, on release profile in terms of the initial drug distribution, diffusivity, degradation rate of gelatin and its ability to form polyionic complex with the drug. By measuring the drug diffusion constant and initial intrapaticle drug distribution in advance, the model can predict the drug release and serve as a design tool for certain drug delivery scenarios. Hydrogel particles with peptide coating were developed as a vehicle for targeted delivery. The proposed drug delivery vehicle contains three main components: (1) anticancer drug, (2) targeting peptide, and (3) drug carrier. In this study, the peptide was used to target Cathepsin D that is overexpressed by breast cancer cells. Gelatin microspheres were utilized as drug carriers which immobilized doxorubicin, an anticancer drug. Uniform gelatin particles (30 µm in diameter, dry) were fabricated via the electric field assisted PPF method to optimize the drug loading efficiency. The particles suitable for intravenous injection (<10 µm, dry) were fabricated by increasing the electric field strength. The results of the release study and chemotherapy on cancer cells, performed in collaboration with Prof. Logan Liu’s group, confirmed that the use of peptide coating as a targeting moiety substantially enhanced the efficacy of chemotherapy, which would alleviate the adverse effect of chemotherapy ascribable to systemic distribution of chemotherapeutics. Alginate microspheres/microcapsules of precisely controlled size and size distribution were employed for cell encapsulation which could be utilized in cell-based therapy and artificial organs. Cell viability was shown to remain intact after the encapsulation. The cross-linking of alginate with calcium ion involved the motion of both alginate molecules and calcium ions. The observation of significant size shrinkage from alginate microdroplets to microspheres indicated a junction-zone mode of the cross-linking process. A particle sorting scheme combining optical detection and electric deflection was developed to deflect out capsules empty of cells and increase the yield in cell encapsulation. This may contribute to reducing the volume of microcapsules required for transplantation and make clinical application more practical. In summary, we have demonstrated the flexibility and practicality of the modified PPF method in producing precision hydrogel particles and the suitability of these particles for applications involving their applications for controlled drug delivery and tissue engineering.","abstract_html":"Hydrogel particles encapsulating biomolecules or living cells are becoming an attractive means to mediate drug delivery or facilitate cell-based treatment of diseases. These particles are capable of maintaining drug stability/cell viability and providing specific drug release profiles. The selection of specific hydrogel and particle size depends on the administration routes, properties of the therapeutics and desired release profiles, and dictates the fabrication methods. We have chosen to design and fabricate hydrogel particles as a means to improve the efficacy of drug delivery utilizing mechanical, hydrodynamic and electric forces (precision particle fabrication (PPF) method and its modified scheme). Using such precision particles, we studied the drug release mechanisms that may help improve the design of new drug delivery vehicles. Monodisperse gelatin microspheres, fabricated via the electric field assisted PPF method, allowed detailed analysis of drug release without uncertainties ascribable to nonuniform particles. The results from this analysis, including zeta potential, particle swelling ratio, and intraparticle drug distributions, led to a release model, based on the reaction-diffusion and Michaelis-Menten kinetics. This model elucidates the effect of glutaraldehyde, a cross-linking agent, on release profile in terms of the initial drug distribution, diffusivity, degradation rate of gelatin and its ability to form polyionic complex with the drug. By measuring the drug diffusion constant and initial intrapaticle drug distribution in advance, the model can predict the drug release and serve as a design tool for certain drug delivery scenarios. Hydrogel particles with peptide coating were developed as a vehicle for targeted delivery. The proposed drug delivery vehicle contains three main components: (1) anticancer drug, (2) targeting peptide, and (3) drug carrier. In this study, the peptide was used to target Cathepsin D that is overexpressed by breast cancer cells. Gelatin microspheres were utilized as drug carriers which immobilized doxorubicin, an anticancer drug. Uniform gelatin particles (30 µm in diameter, dry) were fabricated via the electric field assisted PPF method to optimize the drug loading efficiency. The particles suitable for intravenous injection (&lt;10 µm, dry) were fabricated by increasing the electric field strength. The results of the release study and chemotherapy on cancer cells, performed in collaboration with Prof. Logan Liu’s group, confirmed that the use of peptide coating as a targeting moiety substantially enhanced the efficacy of chemotherapy, which would alleviate the adverse effect of chemotherapy ascribable to systemic distribution of chemotherapeutics. Alginate microspheres/microcapsules of precisely controlled size and size distribution were employed for cell encapsulation which could be utilized in cell-based therapy and artificial organs. Cell viability was shown to remain intact after the encapsulation. The cross-linking of alginate with calcium ion involved the motion of both alginate molecules and calcium ions. The observation of significant size shrinkage from alginate microdroplets to microspheres indicated a junction-zone mode of the cross-linking process. A particle sorting scheme combining optical detection and electric deflection was developed to deflect out capsules empty of cells and increase the yield in cell encapsulation. This may contribute to reducing the volume of microcapsules required for transplantation and make clinical application more practical. In summary, we have demonstrated the flexibility and practicality of the modified PPF method in producing precision hydrogel particles and the suitability of these particles for applications involving their applications for controlled drug delivery and tissue engineering.","abstract_has_math":false,"creators":["Cheng, Felice"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Electrical & Computer Engr","degree_department":null,"school":null,"contributors":["Kim, Kyekyoon","Choi, Hyungsoo","O'Brien, William D.","Hsieh, Kuang-Chien"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-01-21T22:53:05Z","date_published":"2011-01-21T22:53:05Z","updated_at":"2026-07-22T22:25:11Z","subjects":["Hydrogel","drug delivery","cell encapsulation"],"languages":["en"],"rights":["Copyright 2010 Felice Cheng"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/18647","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kim, Kyekyoon","Choi, Hyungsoo","O'Brien, William D.","Hsieh, Kuang-Chien"]},{"key":"dc:creator","label":"Author","values":["Cheng, Felice"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2011-01-21T22:53:05Z","2013-01-22T11:00:18Z","2010-12"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Electrical & Computer Engr"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Hydrogel","drug delivery","cell encapsulation"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2010 Felice Cheng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/18647"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Hydrogel particles encapsulating biomolecules or living cells are becoming an attractive means to mediate drug delivery or facilitate cell-based treatment of diseases. These particles are capable of maintaining drug stability/cell viability and providing specific drug release profiles. The selection of specific hydrogel and particle size depends on the administration routes, properties of the therapeutics and desired release profiles, and dictates the fabrication methods. We have chosen to design and fabricate hydrogel particles as a means to improve the efficacy of drug delivery utilizing mechanical, hydrodynamic and electric forces (precision particle fabrication (PPF) method and its modified scheme). Using such precision particles, we studied the drug release mechanisms that may help improve the design of new drug delivery vehicles. Monodisperse gelatin microspheres, fabricated via the electric field assisted PPF method, allowed detailed analysis of drug release without uncertainties ascribable to nonuniform particles. The results from this analysis, including zeta potential, particle swelling ratio, and intraparticle drug distributions, led to a release model, based on the reaction-diffusion and Michaelis-Menten kinetics. This model elucidates the effect of glutaraldehyde, a cross-linking agent, on release profile in terms of the initial drug distribution, diffusivity, degradation rate of gelatin and its ability to form polyionic complex with the drug. By measuring the drug diffusion constant and initial intrapaticle drug distribution in advance, the model can predict the drug release and serve as a design tool for certain drug delivery scenarios. Hydrogel particles with peptide coating were developed as a vehicle for targeted delivery. The proposed drug delivery vehicle contains three main components: (1) anticancer drug, (2) targeting peptide, and (3) drug carrier. In this study, the peptide was used to target Cathepsin D that is overexpressed by breast cancer cells. Gelatin microspheres were utilized as drug carriers which immobilized doxorubicin, an anticancer drug. Uniform gelatin particles (30 µm in diameter, dry) were fabricated via the electric field assisted PPF method to optimize the drug loading efficiency. The particles suitable for intravenous injection (<10 µm, dry) were fabricated by increasing the electric field strength. The results of the release study and chemotherapy on cancer cells, performed in collaboration with Prof. Logan Liu’s group, confirmed that the use of peptide coating as a targeting moiety substantially enhanced the efficacy of chemotherapy, which would alleviate the adverse effect of chemotherapy ascribable to systemic distribution of chemotherapeutics. Alginate microspheres/microcapsules of precisely controlled size and size distribution were employed for cell encapsulation which could be utilized in cell-based therapy and artificial organs. Cell viability was shown to remain intact after the encapsulation. The cross-linking of alginate with calcium ion involved the motion of both alginate molecules and calcium ions. The observation of significant size shrinkage from alginate microdroplets to microspheres indicated a junction-zone mode of the cross-linking process. A particle sorting scheme combining optical detection and electric deflection was developed to deflect out capsules empty of cells and increase the yield in cell encapsulation. This may contribute to reducing the volume of microcapsules required for transplantation and make clinical application more practical. In summary, we have demonstrated the flexibility and practicality of the modified PPF method in producing precision hydrogel particles and the suitability of these particles for applications involving their applications for controlled drug delivery and tissue engineering.","Item withdrawn by Mark Zulauf (zulauf@illinois.edu) on 2010-11-16T18:10:14Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 2 Cheng_Felice.doc: 10534400 bytes, checksum: b5d14b4c67861f19d13c8de8742f3ab6 (MD5) Cheng_Felice.pdf: 3029173 bytes, checksum: 51c56afbc7c3f63fb122fc183af6e7c0 (MD5)","Made available in DSpace on 2011-01-21T22:53:05Z (GMT). No. of bitstreams: 3 Cheng_Felice.pdf: 3029173 bytes, checksum: 51c56afbc7c3f63fb122fc183af6e7c0 (MD5) license.txt: 4061 bytes, checksum: 70c13724dc834a8a9b7d807058c5b771 (MD5) Cheng_Felice.doc: 10534400 bytes, checksum: b5d14b4c67861f19d13c8de8742f3ab6 (MD5)","Item marked as restricted to the 'Administrator' Group (id=1) by William Ingram (wingram2@illinois.edu) on 2011-01-21T22:54:06Z Item is restricted until 2013-01-21T22:53:34Z","Item reinstated by Sarah Shreeves (sshreeve@illinois.edu) on 2013-01-22T11:00:18Z Item was in collections: University of Illinois Dissertations and Theses (ID: 204) Dissertations and Theses - Electrical and Computer Engineering (ID: 446) No. of bitstreams: 4 Cheng_Felice.pdf.txt: 133372 bytes, checksum: fc9b45f5df6112c624e13b1f74507c3e (MD5) Cheng_Felice.pdf: 3029173 bytes, checksum: 51c56afbc7c3f63fb122fc183af6e7c0 (MD5) license.txt: 4061 bytes, checksum: 70c13724dc834a8a9b7d807058c5b771 (MD5) Cheng_Felice.doc: 10534400 bytes, checksum: b5d14b4c67861f19d13c8de8742f3ab6 (MD5)","Item released from any restrictions by Sarah Shreeves (sshreeve@illinois.edu) on 2013-01-22T11:00:18Z"]},{"key":"dc:title","label":"Title","values":["Study of drug delivery and cell encapsulation using biocompatible hydrogel"]}]}],"canonical_facts":{"dc:contributor":["Kim, Kyekyoon","Choi, Hyungsoo","O'Brien, William D.","Hsieh, Kuang-Chien"],"dc:creator":["Cheng, Felice"],"dc:date":["2011-01-21T22:53:05Z","2013-01-22T11:00:18Z","2010-12"],"dc:description":["Hydrogel particles encapsulating biomolecules or living cells are becoming an attractive means to mediate drug delivery or facilitate cell-based treatment of diseases. These particles are capable of maintaining drug stability/cell viability and providing specific drug release profiles. The selection of specific hydrogel and particle size depends on the administration routes, properties of the therapeutics and desired release profiles, and dictates the fabrication methods. We have chosen to design and fabricate hydrogel particles as a means to improve the efficacy of drug delivery utilizing mechanical, hydrodynamic and electric forces (precision particle fabrication (PPF) method and its modified scheme). Using such precision particles, we studied the drug release mechanisms that may help improve the design of new drug delivery vehicles. Monodisperse gelatin microspheres, fabricated via the electric field assisted PPF method, allowed detailed analysis of drug release without uncertainties ascribable to nonuniform particles. The results from this analysis, including zeta potential, particle swelling ratio, and intraparticle drug distributions, led to a release model, based on the reaction-diffusion and Michaelis-Menten kinetics. This model elucidates the effect of glutaraldehyde, a cross-linking agent, on release profile in terms of the initial drug distribution, diffusivity, degradation rate of gelatin and its ability to form polyionic complex with the drug. By measuring the drug diffusion constant and initial intrapaticle drug distribution in advance, the model can predict the drug release and serve as a design tool for certain drug delivery scenarios. Hydrogel particles with peptide coating were developed as a vehicle for targeted delivery. The proposed drug delivery vehicle contains three main components: (1) anticancer drug, (2) targeting peptide, and (3) drug carrier. In this study, the peptide was used to target Cathepsin D that is overexpressed by breast cancer cells. Gelatin microspheres were utilized as drug carriers which immobilized doxorubicin, an anticancer drug. Uniform gelatin particles (30 µm in diameter, dry) were fabricated via the electric field assisted PPF method to optimize the drug loading efficiency. The particles suitable for intravenous injection (<10 µm, dry) were fabricated by increasing the electric field strength. The results of the release study and chemotherapy on cancer cells, performed in collaboration with Prof. Logan Liu’s group, confirmed that the use of peptide coating as a targeting moiety substantially enhanced the efficacy of chemotherapy, which would alleviate the adverse effect of chemotherapy ascribable to systemic distribution of chemotherapeutics. Alginate microspheres/microcapsules of precisely controlled size and size distribution were employed for cell encapsulation which could be utilized in cell-based therapy and artificial organs. Cell viability was shown to remain intact after the encapsulation. The cross-linking of alginate with calcium ion involved the motion of both alginate molecules and calcium ions. The observation of significant size shrinkage from alginate microdroplets to microspheres indicated a junction-zone mode of the cross-linking process. A particle sorting scheme combining optical detection and electric deflection was developed to deflect out capsules empty of cells and increase the yield in cell encapsulation. This may contribute to reducing the volume of microcapsules required for transplantation and make clinical application more practical. In summary, we have demonstrated the flexibility and practicality of the modified PPF method in producing precision hydrogel particles and the suitability of these particles for applications involving their applications for controlled drug delivery and tissue engineering.","Item withdrawn by Mark Zulauf (zulauf@illinois.edu) on 2010-11-16T18:10:14Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 2 Cheng_Felice.doc: 10534400 bytes, checksum: b5d14b4c67861f19d13c8de8742f3ab6 (MD5) Cheng_Felice.pdf: 3029173 bytes, checksum: 51c56afbc7c3f63fb122fc183af6e7c0 (MD5)","Made available in DSpace on 2011-01-21T22:53:05Z (GMT). No. of bitstreams: 3 Cheng_Felice.pdf: 3029173 bytes, checksum: 51c56afbc7c3f63fb122fc183af6e7c0 (MD5) license.txt: 4061 bytes, checksum: 70c13724dc834a8a9b7d807058c5b771 (MD5) Cheng_Felice.doc: 10534400 bytes, checksum: b5d14b4c67861f19d13c8de8742f3ab6 (MD5)","Item marked as restricted to the 'Administrator' Group (id=1) by William Ingram (wingram2@illinois.edu) on 2011-01-21T22:54:06Z Item is restricted until 2013-01-21T22:53:34Z","Item reinstated by Sarah Shreeves (sshreeve@illinois.edu) on 2013-01-22T11:00:18Z Item was in collections: University of Illinois Dissertations and Theses (ID: 204) Dissertations and Theses - Electrical and Computer Engineering (ID: 446) No. of bitstreams: 4 Cheng_Felice.pdf.txt: 133372 bytes, checksum: fc9b45f5df6112c624e13b1f74507c3e (MD5) Cheng_Felice.pdf: 3029173 bytes, checksum: 51c56afbc7c3f63fb122fc183af6e7c0 (MD5) license.txt: 4061 bytes, checksum: 70c13724dc834a8a9b7d807058c5b771 (MD5) Cheng_Felice.doc: 10534400 bytes, checksum: b5d14b4c67861f19d13c8de8742f3ab6 (MD5)","Item released from any restrictions by Sarah Shreeves (sshreeve@illinois.edu) on 2013-01-22T11:00:18Z"],"dc:identifier":["http://hdl.handle.net/2142/18647"],"dc:language":["en"],"dc:rights":["Copyright 2010 Felice Cheng"],"dc:subject":["Hydrogel","drug delivery","cell encapsulation"],"dc:title":["Study of drug delivery and cell encapsulation using biocompatible hydrogel"],"thesis:degree_discipline":["Electrical & Computer Engr"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:25:11Z"}